Loss of STARD13 contributes to aggressive phenotype transformation and poor prognosis in papillary thyroid carcinoma.
Chuimian ZengHai LiWeiwei LiangJunxin ChenYilin ZhangHanrong ZhangHaipeng XiaoYanbing LiHongyu GuanPublished in: Endocrine (2023)
Our results suggest that STARD13 acts as a metastasis suppressor and might be a potential therapeutic target in PTC.